On February 11, 2022, ThermoGenesis Holdings Inc. (THMO) stock made a comeback in the after-hours to gain 7.19%. There has been no recent official announcement or SEC filing from the company.
The stock remained in the red with a loss of 2.97% in the regular trading session. THMO closed the session at $0.8303 with a below-average volume of 211.82K shares. The stock rebounded in the after-hours and gained $0.06 or 7.19%. Hence, on February 11, THMO stock was trading at a value of $0.8900 per share in the after-hours session.
The cell and gene therapy automated cell processing technologies developer, ThermoGenesis Holdings Inc. has a market capitalization of $9.89 million. Currently, the company has 11.91 million shares outstanding in the market.
Why THMO Rebounded?
There has been no recent announcement or SEC filing from the company to explain the stock’s movement. On Wednesday and Thursday, THMO stock remained bullish to increase from $0.8300 to $0.8600. Following the gain, the stock entered a downtrend on Friday, during the regular session. It seems the stock suffered a downfall due to profit booking from the gains. Subsequently, the stock once again resumed its bullish momentum in the after-hours on Friday.
An overview of the stock’s movement shows a picture in red with losses. THMO has lost 17.79% year to date while it subtracted a huge value of 78.49% last year.
Annual Meeting of Stockholder
The company’s 2021 Annual Meeting of Stockholders was initially set to take place on December 16, 2021. Due to the lack of the required quorum, the meeting was adjourned without conducting business.
The company then reconvened the meeting on Thursday, January 13, 2022, at its corporate headquarters in Rancho Cordova, CA.
Moreover, only the stockholders of the previous record date, October 26, 2021, were allowed to vote in the meeting.
THMO’s Recent Participation
Recently, the company participated in the H.C. Wainwright BioConnect Virtual Conference. The conference took place from January 10 to January 13, 2022. THMO’s Chief Financial Officer, Jeff Cauble presented an overview of the company at the conference.
Financial Analysis
In the third quarter of 2021, the company generated net revenues of $3.2 million against $2.4 million in the year-ago period. This marks an increase of 34% YOY.
Furthermore, THMO incurred a comprehensive net loss of $1.8 million in Q3 2021, against $2.5 million in the prior-year period. Therefore, the net loss per basic and diluted share was $0.15 and $0.37 in the third quarter of 2021 and 2020 respectively.
